Association of obesity with vitamin D deficiency and the clinical implications

Anitha Oommen; Ibrahim Hassan Al-Zahrani

doi:10.18203/2320-6012.ijrms20151173

Authors

Anitha Oommen Department of Anatomy, Northern Border University, Arar, P. O. Box 1321
Ibrahim Hassan Al-Zahrani Department of Pathology, Northern Border University, Arar, P. O. Box 1321

DOI:

https://doi.org/10.18203/2320-6012.ijrms20151173

Keywords:

Vitamin D deficiency, Obesity, Saudi women

Abstract

Background: Obesity is a complex disorder which leads to health problems like diabetes, hypertension and hyper cholesterolemia. It has been reported that obesity is associated with vitamin D insufficiency due to decreased bio-availability. The aim of the present study is to investigate whether vitamin D deficiency can be a causative factor for obesity in Saudi women above 40 years.

Methods: 100 Saudi female patients above 40 years who came to the outpatient department of Arar central hospital were selected for the study. Patients who were on immunosuppressive drugs, with hormonal disorders and with impaired renal function were excluded from the study. The data was collected using a questionnaire which included the socio demographic details, height, weight and medical history and the serum vitamin D levels were assessed.

Results: 69% of the Saudi women were obese (BMI >30). 84% (n=58) of the obese women had vitamin D deficiency (<50 nmols/l) while 69.6% of the overweight women had vitamin D deficiency. 43.5% (n = 30) of obese women had diabetes, 44.9% (n=31) of obese women had hypertension. The association between obesity and vitamin D deficiency was not significant.

Conclusions: No significant association was found between obesity and vitamin D deficiency indicating that vitamin D deficiency has no significant role in causing obesity in Saudi women above 40 years.

Metrics

Metrics Loading ...

References

Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC, et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab. 2011;96:168-75.

Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26:573-80.

Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes. 2012;36:387-96.

Lagunova Z, Porojnicu AC, Vieth R, Lindberg FA, Hexeberg S, Moan J. Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J Nutr. 2011;141:112-7.

Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009;29:3713-20.

Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89:1196-9.

Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr. 2008;47:87-91.

Garanty-Bogacka B, Syrenicz M, Goral J, Krupa B, Syrenicz J, Walczak M, et al. Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents. Endokrynol Pol. 2011;62:506-11.

Tamer G, Mesci B, Tamer I, Kilic D, Arik S. Is vitamin D deficiency an independent risk factor for obesity and abdominal obesity in women? Endokrynol Pol. 2012;63:196-201.

Lee SH, Kim SM, Park HS, Choi KM, Cho GJ, Ko BJ, et al. Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children. Nutr Metab Cardiovasc Dis. 2012;22:1-7.

Vashi PG, Lammersfeld CA, Braun DP, Gupta D. Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J. 2011;10:51.

Al-Baghli NA, Al-Ghamdi AJ, Al-Turki KA, El-Zubaier AG, Al-Ameer MM, Al-Baghli FA. Overweight and obesity in the Eastern province of Saudi Arabia. Saudi Med J. 2008;29(9):1319-25.

Memish ZA, El Bcheraoui C, Tuffaha M, Robinson M, Daoud F, Jaber S, et al. Obesity and associated factors - Kingdom of Saudi Arabia, 2013. Prev Chronic Dis. 2014;11:140236.

Oommen A, AlZahrani I. Prevalence of osteoporosis and factors associated with osteoporosis in women above 40 years in the Northern part of Saudi Arabia. Int J Res Med Sci. 2014;2:274-8.

Gallagher JC, Sai AJ. Vitamin D Insufficiency, deficiency, and bone health. J Clin Endocrinol Metab. 2010;95:2630-3.

Hashemipour S, Larijani B, Sedaghat HAM, Mohammad MP, Bastan-Hagh H, A Javadi ASE, et al. The status of biochemical parameters in varying degrees of vitamin D deficiency. J Bone Miner Metab. 2006;24:213-8.

Khorvash F, Mottaghi T, Askari G, Maracy MR, Ghiasvand R, Maghsoudi Z, et al. the association between serum vitamin D levels with general and abdominal obesity among patients with migraine. Int J Prev Med. 2013;4n:S313-7.

Wagner B, Klinitzke G, Brahler E, Kersting A. Extreme obesity is associated with suicidal behavior and suicide attempts in adults: results of a population-based representative sample. Depress Anxiety. 2013;10:975-81.

Foss YJ. Vitamin D deficiency is the cause of common obesity. Med Hypotheses. 2009;3:314-21.

Reichel H, Koeffler HP, Norman AW. the role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989;320:980-91.

Narvaez CJ, Matthews D, Broun E, Chan M, Welsh JE. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology. 2009;150(2):651-61.

Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci. 2008;105:5266-70.

Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr. 2014 May; 99(5):1015-25.

McCarty MF. Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med Hypotheses. 2009;72:647-51.

Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes. 2010;17:113-9.

Moy FM, Bulgiba A. High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia. BMC Public Health. 2011;11:735.

Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest. 1985;76:370-3.

Lương KVQ, Nguyễn LTH. The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutr J. 2013;12:89.

Cândido FG, Bressan J. Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci. 2014;15(4):6569-91.

Vanlint S. Vitamin D and obesity. Nutrients. 2013;5(3):949-56.